Impact Healthcare REIT (LSE: IHR)

Currency in GBP

Last close As at 09/06/2023


−1.10 (−1.11%)

Market capitalisation


Impact Healthcare REIT (IHR) invests in a diversified portfolio of UK healthcare assets, particularly residential and nursing care homes, let on long leases to high-quality operators. It aims to provide shareholders with attractive and sustainable returns, primarily in the form of dividends.

Care home demand is driven by demographics and care needs and benefits from supportive demand fundamentals including increasing requirements from a rapidly ageing population for high quality care and a need to reduce pressure on high-cost, medical care providers in the NHS.


Real Estate

Equity Analyst

Martyn King

Martyn King

Director, Financials

Key Management

  • Andrew Cowley

    Managing partner, Impact Health Partners

  • David Yaldron


  • Rupert Barclay

    Non-executive chairman

Balance Sheet

Forecast net cash (£m)


Forecast gearing ratio (%)


Share Price Performance

Price Performance
% 1M 3M 12M
Actual (0.5) (1.3) (20.5)
Relative 1.7 2.9 (19.7)
52 week high/low 124.0p/90.1p


IHR’s strong financial and operational performance continued through Q123, benefiting from the resilience and growth of the portfolio and indexed rent increases. Meanwhile, earnings are significantly protected from interest rate increases with the costs on 80% of debt fixed/hedged. FY22 DPS was fully covered, 128% by EPRA earnings (+4% per share) and 109% by adjusted cash earnings (+6%) and a Q123 DPS of 1.6925p is in line with the FY23 target of 6.77p (+3.5%). Tenant rent cover remains strong at c 1.8x and we do not believe that the single tenant in arrears is indicative of wider tenant stress as strong fee growth and rising occupancy continues to provide an offset to inflationary pressures. With the property valuation yield little changed in Q123, rent growth generated a positive 1.8% property gain and unaudited NAV per share increased 2.2% to 112.6p. Including DPS paid, the three-month NAV total return was 3.7%.

Y/E Dec Revenue (£m) EBITDA (£m) PBT (£m) EPS (p) P/E (x) P/CF (x)
2021A 36.5 31.0 27.4 8.1 12.1 N/A
2022A 45.4 38.6 32.6 8.4 11.7 13.0
2023E 53.1 45.1 35.2 8.5 11.6 N/A
2024E 55.5 47.2 36.5 8.8 11.2 12.1



IPO apocalypse


ESG, moving beyond the box tick

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free